The functional role of Notch signaling in human gliomas.

Gliomas are among the most devastating adult tumors for which there is currently no cure. The tumors are derived from brain glial tissue and comprise several diverse tumor forms and grades. Recent reports highlight the importance of cancer-initiating cells in the malignancy of gliomas. These cells have been referred to as brain cancer stem cells (bCSC), as they share similarities to normal neural stem cells in the brain. The Notch signaling pathway is involved in cell fate decisions throughout normal development and in stem cell proliferation and maintenance. The role of Notch in cancer is now firmly established, and recent data implicate a role for Notch signaling also in gliomas and bCSC. In this review, we explore the role of the Notch signaling pathway in gliomas with emphasis on its role in normal brain development and its interplay with pathways and processes that are characteristic of malignant gliomas.

[1]  F. Kuo,et al.  Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor , 1997, Molecular and cellular biology.

[2]  B. Barres,et al.  Notch Receptor Activation Inhibits Oligodendrocyte Differentiation , 1998, Neuron.

[3]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[4]  Y. Jan,et al.  The Drosophila neurogenic gene neuralized encodes a novel protein and is expressed in precursors of larval and adult neurons. , 1991, The EMBO journal.

[5]  R. Britto,et al.  Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma , 2005, Oncogene.

[6]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[7]  J. Boulter,et al.  Jagged: A mammalian ligand that activates notch1 , 1995, Cell.

[8]  W. Huttner,et al.  Isolation of neural stem cells from the postnatal cerebellum , 2005, Nature Neuroscience.

[9]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Keith Brennan,et al.  CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? , 2002, Current opinion in genetics & development.

[11]  A. Shiras,et al.  Spontaneous Transformation of Human Adult Nontumorigenic Stem Cells to Cancer Stem Cells Is Driven by Genomic Instability in a Human Model of Glioblastoma , 2007, Stem cells.

[12]  T. Yagi,et al.  Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells. , 1993, Oncogene.

[13]  Gabriele Bergers,et al.  Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.

[14]  Gavin Thurston,et al.  Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Wen Shi,et al.  Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. , 2007, Cancer research.

[16]  U. Lendahl,et al.  Notch and neurogenesis , 1998, Journal of neuroscience research.

[17]  A. Capobianco,et al.  Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic , 2001, Molecular and Cellular Biology.

[18]  R. Evans,et al.  A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. , 1998, Genes & development.

[19]  W. Richards,et al.  Dll4, a novel Notch ligand expressed in arterial endothelium. , 2000, Genes & development.

[20]  C. Sawyers.  Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics. , 2002, Cancer cell.

[21]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.

[22]  Damian Brunner,et al.  Tea2p kinesin is involved in spatial microtubule organization by transporting tip1p on microtubules. , 2004, Developmental cell.

[23]  S. Artavanis-Tsakonas,et al.  Intracellular Cleavage of Notch Leads to a Heterodimeric Receptor on the Plasma Membrane , 1997, Cell.

[24]  P. Steinbok,et al.  Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme , 1984, Journal of Neuro-Oncology.

[25]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Beddington,et al.  Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. , 1997, Development.

[27]  M. Kosteljanetz,et al.  Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours , 2009, Acta oncologica.

[28]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[29]  A. Israël,et al.  The Notch1 receptor is cleaved constitutively by a furin-like convertase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A Cumano,et al.  A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.

[31]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[32]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[33]  Ling Lin,et al.  TGF‐α induces upregulation and nuclear translocation of Hes1 in glioma cell , 2008, Cell biochemistry and function.

[34]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[35]  N. Socci,et al.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.

[36]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[37]  D. Xie,et al.  DLK1: increased expression in gliomas and associated with oncogenic activities , 2006, Oncogene.

[38]  Q. Su,et al.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.

[39]  W. Hahn,et al.  Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells , 2002, Nature Medicine.

[40]  Raphael Kopan,et al.  A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. , 2000, Molecular cell.

[41]  G. B. Hassin.  THE RISE OF NEUROPATHOLOGY , 1942 .

[42]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[43]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[44]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[45]  P. Leder,et al.  Ras pathway signals are required for notch-mediated oncogenesis , 2000, Oncogene.

[46]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[47]  A. Moscona.  Squamous metaplasia and keratinization of chorionic epithelium of the chick embryo in egg and in culture , 1959 .

[48]  S. Weiss,et al.  Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. , 1996, Developmental biology.

[49]  Q. Su,et al.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.

[50]  J. Robertson,et al.  Assessment of adjacent-segment disease in patients treated with cervical fusion or arthroplasty: a prospective 2-year study. , 2005, Journal of neurosurgery. Spine.

[51]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[52]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[53]  L. Nguyen,et al.  Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. , 2006, Developmental cell.

[54]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[55]  Gord Fishell,et al.  The role of notch in promoting glial and neural stem cell fates. , 2002, Annual review of neuroscience.

[56]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[57]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[58]  Jay S. Fine,et al.  Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.

[59]  T. F. O'Brien,et al.  Multipotent Stem/Progenitor Cells with Similar Properties Arise from Two Neurogenic Regions of Adult Human Brain , 1999, Experimental Neurology.

[60]  B. Birlik,et al.  Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas , 2006, Neuropathology and applied neurobiology.

[61]  A. Wilkins,et al.  The molecular elements that underlie developmental evolution , 2005, Nature Reviews Genetics.

[62]  D. Ward,et al.  Human ligands of the Notch receptor. , 1999, The American journal of pathology.

[63]  Clive N Svendsen,et al.  A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.

[64]  J. Boulter,et al.  The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands , 2005, The Journal of cell biology.

[65]  W. Yung,et al.  The autocrine loop of TGF-α/EGFR and brain tumors , 1997, Journal of Neuro-Oncology.

[66]  David J Anderson,et al.  Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells , 2000, Cell.

[67]  Martin Raff,et al.  Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals , 2002, Nature Neuroscience.

[68]  D. Yew,et al.  Effects of hypoxia on the proliferation and differentiation of NSCs , 2007, Molecular Neurobiology.

[69]  M. Minchin,et al.  Veratrum alkaloids as transmitter-releasing agents , 1980, Journal of Neuroscience Methods.

[70]  N. Gaiano,et al.  Notch signaling in the mammalian central nervous system: insights from mouse mutants , 2005, Nature Neuroscience.

[71]  Y. Yonekawa,et al.  PTEN (MMAC1) Mutations Are Frequent in Primary Glioblastomas (de novo) but not in Secondary Glioblastomas , 1998, Journal of neuropathology and experimental neurology.

[72]  K. Helin,et al.  A role for the transcription factor HEY1 in glioblastoma , 2008, Journal of cellular and molecular medicine.

[73]  Koji Yoshimoto,et al.  Primary Glioblastomas Express Mesenchymal Stem-Like Properties , 2006, Molecular Cancer Research.

[74]  Haipeng Cheng,et al.  Characterization of human LNX, a novel ligand of Numb protein X that is downregulated in human gliomas. , 2005, The international journal of biochemistry & cell biology.

[75]  Yan Li,et al.  Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis , 2003, Molecular and Cellular Biology.

[76]  D. Farkas,et al.  Isolation of cancer stem cells from adult glioblastoma multiforme , 2004, Oncogene.

[77]  Hans Clevers,et al.  Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.

[78]  Minhong Yan,et al.  Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.

[79]  U. Lendahl,et al.  Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms. , 2008, Current opinion in genetics & development.

[80]  S. Dulchavsky,et al.  Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-κB and Notch1 signaling , 2007, Journal of Neuro-Oncology.

[81]  W. Pear,et al.  Notch and cancer: best to avoid the ups and downs. , 2003, Cancer cell.

[82]  Cun-Yu Wang,et al.  Notch signaling in the regulation of tumor angiogenesis. , 2006, Trends in cell biology.

[83]  T. Giordano,et al.  Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.

[84]  D. Zagzag,et al.  Angiogenesis in Gliomas: Biology and Molecular Pathophysiology , 2005, Brain pathology.

[85]  L. Recht,et al.  A method for clonal analysis of epidermal growth factor-responsive neural progenitors , 2002, Journal of Neuroscience Methods.

[86]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[87]  Hong Wu,et al.  Notch Signaling, Brain Development, and Human Disease , 2005, Pediatric Research.

[88]  Cheryl Wolting,et al.  LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin‐dependent degradation , 2002, The EMBO journal.

[89]  N. Patel,et al.  Inhibition of angiogenesis and tumor growth by and ?-secretase inhibitors , 2005 .

[90]  P. Goymer.  Plant development: A time and a place for flowers , 2005, Nature Reviews Genetics.

[91]  Raphael Kopan,et al.  An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. , 1994, Development.

[92]  M. Rosenblum,et al.  Expression of transforming growth factor alpha in human gliomas. , 1990, Oncogene.

[93]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[94]  G. Zheng,et al.  Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells , 2007, Molecular and Cellular Biochemistry.

[95]  Adrian L Harris,et al.  Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. , 2005, Cancer research.

[96]  Gavin Thurston,et al.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.

[97]  S. Cohen,et al.  Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. , 1984, Carcinogenesis.

[98]  N. Andén.  Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system. , 1967, European journal of pharmacology.

[99]  H. Kuhlenbeck,et al.  THE SUBEPENDYMAL CELL PLATE (MATRIX) AND ITS RELATIONSHIP TO BRAIN TUMORS OF THE EPENDYMAL TYPE , 1944 .

[100]  M. Hatten,et al.  Activated Notch2 Signaling Inhibits Differentiation of Cerebellar Granule Neuron Precursors by Maintaining Proliferation , 2001, Neuron.

[101]  E. Holland,et al.  Notch signaling enhances nestin expression in gliomas. , 2006, Neoplasia.

[102]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[103]  G. Weinmaster,et al.  Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch‐DSL signaling system during brain development , 2001, The Journal of comparative neurology.

[104]  D. Stearns,et al.  Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.

[105]  E. Lai.  Protein Degradation: Four E3s For The Notch Pathway , 2002, Current Biology.

[106]  W. Ge,et al.  Notch signaling promotes astrogliogenesis via direct CSL‐mediated glial gene activation , 2002, Journal of neuroscience research.

[107]  R Bicknell,et al.  Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. , 2001, Differentiation; research in biological diversity.

[108]  E. Sausville,et al.  dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. , 1993, The Journal of biological chemistry.

[109]  Ali Shilatifard,et al.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis , 2010, Nature Reviews Cancer.

[110]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[111]  Darell D. Bigner,et al.  Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma , 2007, Clinical Cancer Research.

[112]  Mitchel S Berger,et al.  Contribution of Notch signaling activation to human glioblastoma multiforme. , 2007, Journal of neurosurgery.

[113]  T. Honjo,et al.  Functional Interaction between the Mouse Notch1 Intracellular Region and Histone Acetyltransferases PCAF and GCN5* , 2000, The Journal of Biological Chemistry.

[114]  J. Kleinman,et al.  Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone , 2000, The Journal of comparative neurology.

[115]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[116]  T. Golub,et al.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. , 2004, Cancer cell.

[117]  Ryoichiro Kageyama,et al.  Roles of bHLH genes in neural stem cell differentiation. , 2005, Experimental cell research.

[118]  Mitsuyoshi Nakao,et al.  Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region , 1998, Oncogene.

[119]  H. Axelson,et al.  Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. , 2005, Experimental cell research.

[120]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[121]  D. O’Rourke,et al.  Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. , 2000, Cancer research.

[122]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.